Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J.
Cbr Laboratories, Inc., Boston, MA, United States
Search 3 grants from Robert Mandle
Search grants from Cbr Laboratories, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Training Program in Surgical Oncology
Alcohol Research Collabortive: Peer Programs
Impaired Temporal Resolution in Familial Dyslexia
Regulation of Alpha and Beta Subunits of Tsh
SGER: Reverse Engineering Cellular Pathways from Human Cells Exposed to Nanomaterials-Development of Novel Risk Assessment Methods
Recently added grants:
Develop General Methods for the Synthesis of Proteins with Posttranslational Lysine Modifications
Identifying Biomarkers from Multi-source, Multi-way Data
Mechanisms of fibrosis in post-surgical lymphedema
Lagrangian computational modeling for biomedical data science
Zebrafish Development and Genetics Conference
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44HL052290-03
Application #
2229597
Study Section
Special Emphasis Panel (ZRG7-SSS-Z (18))
Project Start
1993-08-10
Project End
1998-04-30
Budget Start
1996-05-01
Budget End
1998-04-30
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Cbr Laboratories, Inc.
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1996
R44 HL
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J. / Cbr Laboratories, Inc.
NIH 1995
R44 HL
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J. / Cbr Laboratories, Inc.
Comments
Be the first to comment on Robert Mandle's grant